| Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The lancet respiratory medicine 7 (1), 46-59, 2019 | 288 | 2019 |
| Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study A Menzies-Gow, ME Wechsler, CE Brightling, S Korn, J Corren, E Israel, ... The Lancet Respiratory Medicine 11 (5), 425-438, 2023 | 46 | 2023 |
| Nitric oxide metabolism in patients with community-acquired pneumonia associated with coronary heart disease and the possibility of its medicamentous management MM Ostrovskyy, OI Varunkiv, LD Todoriko, IO Savelikhina, ... Wiadomości Lekarskie, VOL. UME LXXIII, 1707-1711, 2020 | 13 | 2020 |
| Osoblyvosti perebigu tuberkulozu v umovakh pandemiyi COVID-19 (Features of the course of tuberculosis in the COVID-19 pandemic) LD Todoriko, MM Ostrovskyy, IO Semyaniv Tuberkuloz, legenevi khvoroby, VIL-infektsiya 43 (4), 52-63, 2020 | 11 | 2020 |
| Systemic inflammatory markers and overweight in patients suffering from chronic obstructive pulmonary disease with ІІІ degree of bronchial obstruction M Ostrovskyy, N Korzh pathology 21, 25, 2019 | 8 | 2019 |
| Proinflammatory cytokine IL-6 detetion in severe COPD patients: Focus on roflumilast I Savelikhina, M Ostrovskyy, K Ostrovska, M Kulynych-Miskiv, O Varunkiv European Respiratory Journal 52 (suppl 62), 2018 | 8 | 2018 |
| Molnupiravir for intra-household prevention of COVID-19: the MOVe-AHEAD randomized, placebo-controlled trial SA Alpizar, J Accini, DC Anderson, B Eysa, I Medina-Piñón, N Ohmagari, ... Journal of Infection 87 (5), 392-402, 2023 | 4 | 2023 |
| Dynamics of systemic inflammatory markers in case of exacerbation of COPD (III degree of bronchial obstruction) in overweight patients with the optimization of management and … NV Korzh, MM Ostrovskyy pathology 2 (4), 5, 2021 | 3 | 2021 |
| Improved quality of life and dyspnea with erdosteine in COVID-19 patients after hospital discharge Y Feshchenko, M Ostrovskyy, O Varunkiv, N Horovenko Minerva Respiratory Medicine, 2022 | 2 | 2022 |
| C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast M Ostrovskyy, I Savelikhina, K Ostrovska, O Varunkiv, G Korzh, ... European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| THE IMPLICATION OF SOLUBLE MOLECULES OF CELLULAR ADHESION IN THE PROGRESSION OF COPD IN OVERWEIGHT PATIENTS NV Korzh, MM Ostrovskyy Art of Medicine, 27-32, 2021 | 2 | 2021 |
| Side effects of inhaled budesonide through different types of inhalers O Varunkiv, K Ostrovska, M Ostrovskyy, I Savelikhina, N Korzh European Respiratory Journal 54 (suppl 63), 2019 | 2 | 2019 |
| Epidemiology of sarcoidosis in Western Ukraine M Ostrovskyy, K Ostrovska, K Shvets, I Savelikhina, O Varunkiv, N Korzh European Respiratory Journal 54 (suppl 63), 2019 | 2 | 2019 |
| Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine OS Pedersen, T Butova, V Kapustnyk, V Miasoiedov, M Kuzhko, ... Clinical Microbiology and Infection 30 (3), 360-367, 2024 | 1 | 2024 |
| The impact of overweight on the quality of life of patients with COPD GOLD III N Korzh, M Ostrovskyy, G Korzh, O Varunkiv, I Savelikhina, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| The modifying effect of comorbidity on the detection and treatment outcomes of tuberculosis I Makoida, M Ostrovskyy, I Kostitska, O Molodovets, O Melnuk-Sheremeta, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Dynamics of iron content in bronchoalveolar fluid in COPD patients A Zuban, M Ostrovskyy, M Kulynych-Miskiv, I Savelikhina, O Varunkiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Interpreting the significance of collagen-IV level changes in bronchoalveolar fluid in acute COPD exacerbation before and after tiotropium bromide treatment M Kulynych-Miskiv, M Ostrovskyy, V Miskiv, I Savelikhina, O Varunkiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| The effectiveness of rehabilitation programs depending on the COPD risk group K Shvets, M Ostrovskyy, O Varunkiv, I Savelikhina, M Kulynych-Miskiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD I Savelikhina, M Ostrovskyy, A Zuban, O Varunkiv, M Kulynych-Miskiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
